{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "5d6516c9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# Load the dataset\n",
    "ob = pd.read_excel(\n",
    "    r\"C:\\Users\\Grove\\OneDrive\\Documents\\PYTHON\\Datasets\\OB - Products - Dec 2018.xlsx\",\n",
    "    dtype=str\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "554cb64f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of records: 36458\n",
      "\n",
      "Column names:\n",
      "['Ingredient', 'DF;Route', 'Trade_Name', 'Applicant', 'Strength', 'Appl_Type', 'Appl_No', 'Product_No', 'TE_Code', 'Approval_Date', 'RLD', 'RS', 'Type', 'Applicant_Full_Name']\n",
      "\n",
      "Sample data:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BUDESONIDE</td>\n",
       "      <td>AEROSOL, FOAM;RECTAL</td>\n",
       "      <td>UCERIS</td>\n",
       "      <td>VALEANT PHARMS INTL</td>\n",
       "      <td>2MG/ACTUATION</td>\n",
       "      <td>N</td>\n",
       "      <td>205613</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-10-07 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>VALEANT PHARMACEUTICALS INTERNATIONAL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>AEROSOL, FOAM;TOPICAL</td>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>PERRIGO UK FINCO</td>\n",
       "      <td>0.0012</td>\n",
       "      <td>A</td>\n",
       "      <td>78337</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2012-11-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PERRIGO UK FINCO LTD PARTNERSHIP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>AEROSOL, FOAM;TOPICAL</td>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>RICONPHARMA LLC</td>\n",
       "      <td>0.0012</td>\n",
       "      <td>A</td>\n",
       "      <td>207144</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2017-05-24 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>RICONPHARMA LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>AEROSOL, FOAM;TOPICAL</td>\n",
       "      <td>BETAMETHASONE VALERATE</td>\n",
       "      <td>TARO PHARM</td>\n",
       "      <td>0.0012</td>\n",
       "      <td>A</td>\n",
       "      <td>208204</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2017-05-24 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>TARO PHARMACEUTICAL INDUSTRIES LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CLINDAMYCIN PHOSPHATE</td>\n",
       "      <td>AEROSOL, FOAM;TOPICAL</td>\n",
       "      <td>CLINDAMYCIN PHOSPHATE</td>\n",
       "      <td>PERRIGO UK FINCO</td>\n",
       "      <td>0.01</td>\n",
       "      <td>A</td>\n",
       "      <td>90785</td>\n",
       "      <td>1</td>\n",
       "      <td>AT</td>\n",
       "      <td>2010-03-31 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PERRIGO UK FINCO LTD PARTNERSHIP</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               Ingredient               DF;Route              Trade_Name  \\\n",
       "0              BUDESONIDE   AEROSOL, FOAM;RECTAL                  UCERIS   \n",
       "1  BETAMETHASONE VALERATE  AEROSOL, FOAM;TOPICAL  BETAMETHASONE VALERATE   \n",
       "2  BETAMETHASONE VALERATE  AEROSOL, FOAM;TOPICAL  BETAMETHASONE VALERATE   \n",
       "3  BETAMETHASONE VALERATE  AEROSOL, FOAM;TOPICAL  BETAMETHASONE VALERATE   \n",
       "4   CLINDAMYCIN PHOSPHATE  AEROSOL, FOAM;TOPICAL   CLINDAMYCIN PHOSPHATE   \n",
       "\n",
       "             Applicant       Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "0  VALEANT PHARMS INTL  2MG/ACTUATION         N  205613          1     NaN   \n",
       "1     PERRIGO UK FINCO         0.0012         A   78337          1      AB   \n",
       "2      RICONPHARMA LLC         0.0012         A  207144          1      AB   \n",
       "3           TARO PHARM         0.0012         A  208204          1      AB   \n",
       "4     PERRIGO UK FINCO           0.01         A   90785          1      AT   \n",
       "\n",
       "         Approval_Date  RLD   RS Type                    Applicant_Full_Name  \n",
       "0  2014-10-07 00:00:00  Yes  Yes   RX  VALEANT PHARMACEUTICALS INTERNATIONAL  \n",
       "1  2012-11-26 00:00:00   No   No   RX       PERRIGO UK FINCO LTD PARTNERSHIP  \n",
       "2  2017-05-24 00:00:00   No   No   RX                        RICONPHARMA LLC  \n",
       "3  2017-05-24 00:00:00   No   No   RX     TARO PHARMACEUTICAL INDUSTRIES LTD  \n",
       "4  2010-03-31 00:00:00   No   No   RX       PERRIGO UK FINCO LTD PARTNERSHIP  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(f\"Number of records: {len(ob)}\")\n",
    "print(\"\\nColumn names:\")\n",
    "print(ob.columns.tolist())\n",
    "print(\"\\nSample data:\")\n",
    "ob.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "23c50fc8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of OXYCODONE HYDROCHLORIDE records: 252\n",
      "\n",
      "Unique DF;Route combinations for OXYCODONE HYDROCHLORIDE:\n",
      "['CAPSULE, EXTENDED RELEASE;ORAL' 'CAPSULE;ORAL' 'SOLUTION;ORAL'\n",
      " 'TABLET, EXTENDED RELEASE;ORAL' 'TABLET;ORAL']\n",
      "\n",
      "Unique Strengths for OXYCODONE HYDROCHLORIDE:\n",
      "['1.2MG;10MG' '2.4MG;20MG' '3.6MG;30MG' '4.8MG;40MG' '7.2MG;60MG'\n",
      " '9.6MG;80MG' '500MG;5MG' '5MG' '500MG;4.5MG;0.38MG' '325MG;5MG'\n",
      " '325MG/5ML;5MG/5ML' '300MG/5ML;10MG/5ML' '5MG/5ML' '100MG/5ML' '10MG'\n",
      " '15MG' '20MG' '30MG' '40MG' '60MG' '80MG' '5MG;10MG' '10MG;20MG'\n",
      " '20MG;40MG' '325MG;7.5MG' '325MG;4.5MG;0.38MG'\n",
      " '400MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**'\n",
      " '7.5MG' '500MG;2.5MG' '325MG;2.5MG' '325MG;10MG' '500MG;7.5MG'\n",
      " '650MG;10MG' '300MG;2.5MG' '300MG;5MG' '300MG;7.5MG' '300MG;10MG'\n",
      " '400MG;2.5MG' '400MG;5MG' '400MG;7.5MG' '400MG;10MG' '500MG;10MG'\n",
      " '325MG;4.8355MG' '325MG;2.25MG;0.19MG'\n",
      " '325MG;4.5MG;0.38MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**'\n",
      " '325MG;2.25MG;0.19MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**']\n",
      "\n",
      "Unique Application Types for OXYCODONE HYDROCHLORIDE:\n",
      "['N' 'A']\n",
      "\n",
      "Number of OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg records: 0\n",
      "\n",
      "Application types in this subset:\n",
      "Series([], Name: count, dtype: int64)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Ingredient, DF;Route, Trade_Name, Applicant, Strength, Appl_Type, Appl_No, Product_No, TE_Code, Approval_Date, RLD, RS, Type, Applicant_Full_Name]\n",
       "Index: []"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Let's explore the OXYCODONE HYDROCHLORIDE example\n",
    "# First, check if it exists in the dataset\n",
    "oxycodone_data = ob[ob['Ingredient'].str.contains('OXYCODONE HYDROCHLORIDE', na=False)]\n",
    "print(f\"Number of OXYCODONE HYDROCHLORIDE records: {len(oxycodone_data)}\")\n",
    "\n",
    "# Check the unique dosage forms and routes for OXYCODONE HYDROCHLORIDE\n",
    "print(\"\\nUnique DF;Route combinations for OXYCODONE HYDROCHLORIDE:\")\n",
    "print(oxycodone_data['DF;Route'].unique())\n",
    "\n",
    "# Check the unique strengths\n",
    "print(\"\\nUnique Strengths for OXYCODONE HYDROCHLORIDE:\")\n",
    "print(oxycodone_data['Strength'].unique())\n",
    "\n",
    "# Check the unique application types\n",
    "print(\"\\nUnique Application Types for OXYCODONE HYDROCHLORIDE:\")\n",
    "print(oxycodone_data['Appl_Type'].unique())\n",
    "\n",
    "# Create a subset specifically for OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg\n",
    "oxycodone_subset = oxycodone_data[\n",
    "    (oxycodone_data['DF;Route'] == 'TABLET;ORAL') & \n",
    "    (oxycodone_data['Strength'] == '10 mg')\n",
    "]\n",
    "print(f\"\\nNumber of OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg records: {len(oxycodone_subset)}\")\n",
    "print(\"\\nApplication types in this subset:\")\n",
    "print(oxycodone_subset['Appl_Type'].value_counts())\n",
    "\n",
    "oxycodone_subset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "d7b86793",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Does OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg have an NDA therapeutic equivalent? False\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# Let's define a function to check if an ANDA has a corresponding NDA therapeutic equivalent\n",
    "def check_therapeutic_equivalent(df, api, df_route, strength):\n",
    "    \"\"\"\n",
    "    Check if there's a therapeutic equivalent (NDA - 'N') for a given ANDA drug\n",
    "    with the same API, DF;Route, and Strength\n",
    "    \n",
    "    Parameters:\n",
    "    -----------\n",
    "    df : DataFrame\n",
    "        The DataFrame containing the drug data\n",
    "    api : str\n",
    "        The API (Ingredient) to check\n",
    "    df_route : str\n",
    "        The DF;Route to check\n",
    "    strength : str\n",
    "        The Strength to check\n",
    "        \n",
    "    Returns:\n",
    "    --------\n",
    "    bool\n",
    "        True if a therapeutic equivalent NDA exists, False otherwise\n",
    "    \"\"\"\n",
    "    # Check if any 'N' type application exists with the same API, DF;Route and Strength\n",
    "    nda_exists = len(df[\n",
    "        (df['Ingredient'] == api) & \n",
    "        (df['DF;Route'] == df_route) & \n",
    "        (df['Strength'] == strength) & \n",
    "        (df['Appl_Type'] == 'N')\n",
    "    ]) > 0\n",
    "    \n",
    "    return nda_exists\n",
    "\n",
    "# Let's verify our test case with OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg\n",
    "# We expect this to return False as per your example\n",
    "api = 'OXYCODONE HYDROCHLORIDE'\n",
    "df_route = 'TABLET;ORAL'\n",
    "strength = '10MG'\n",
    "\n",
    "has_therapeutic_equivalent = check_therapeutic_equivalent(ob, api, df_route, strength)\n",
    "print(f\"Does OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg have an NDA therapeutic equivalent? {has_therapeutic_equivalent}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3cfb2734",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total ANDA applications: 26830\n",
      "ANDAs without therapeutic equivalents: 9016\n",
      "\n",
      "Our example found in results: False\n",
      "Number of OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg ANDAs without therapeutic equivalents: 0\n",
      "\n",
      "First few ANDAs without therapeutic equivalents:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>EPIFOAM</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>86457</td>\n",
       "      <td>1</td>\n",
       "      <td>BX</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN SPECIALTY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>89440</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-17 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>GENUS LIFESCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>PROCTOFOAM HC</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>86195</td>\n",
       "      <td>1</td>\n",
       "      <td>BX</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN SPECIALTY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>DEXAMETHASONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>AEROSEB-DEX</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "      <td>0.01% **Federal Register determination that pr...</td>\n",
       "      <td>A</td>\n",
       "      <td>83296</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ALLERGAN HERBERT DIV ALLERGAN INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>HYDROCORTISONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>AEROSEB-HC</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "      <td>0.005</td>\n",
       "      <td>A</td>\n",
       "      <td>85805</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ALLERGAN HERBERT DIV ALLERGAN INC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          Ingredient  \\\n",
       "104  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "106  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "107  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "112                                    DEXAMETHASONE   \n",
       "113                                   HYDROCORTISONE   \n",
       "\n",
       "                     DF;Route  \\\n",
       "104  AEROSOL, METERED;TOPICAL   \n",
       "106  AEROSOL, METERED;TOPICAL   \n",
       "107  AEROSOL, METERED;TOPICAL   \n",
       "112           AEROSOL;TOPICAL   \n",
       "113           AEROSOL;TOPICAL   \n",
       "\n",
       "                                            Trade_Name            Applicant  \\\n",
       "104                                            EPIFOAM  MYLAN SPECIALITY LP   \n",
       "106  HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...   GENUS LIFESCIENCES   \n",
       "107                                      PROCTOFOAM HC  MYLAN SPECIALITY LP   \n",
       "112                                        AEROSEB-DEX     ALLERGAN HERBERT   \n",
       "113                                         AEROSEB-HC     ALLERGAN HERBERT   \n",
       "\n",
       "                                              Strength Appl_Type Appl_No  \\\n",
       "104                                              1%;1%         A   86457   \n",
       "106                                              1%;1%         A   89440   \n",
       "107                                              1%;1%         A   86195   \n",
       "112  0.01% **Federal Register determination that pr...         A   83296   \n",
       "113                                              0.005         A   85805   \n",
       "\n",
       "    Product_No TE_Code                  Approval_Date RLD  RS   Type  \\\n",
       "104          1      BX  Approved Prior to Jan 1, 1982  No  No     RX   \n",
       "106          1     NaN            1988-05-17 00:00:00  No  No  DISCN   \n",
       "107          1      BX  Approved Prior to Jan 1, 1982  No  No     RX   \n",
       "112          2     NaN  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "113          1     NaN  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "\n",
       "                   Applicant_Full_Name  \n",
       "104                 MYLAN SPECIALTY LP  \n",
       "106             GENUS LIFESCIENCES INC  \n",
       "107                 MYLAN SPECIALTY LP  \n",
       "112  ALLERGAN HERBERT DIV ALLERGAN INC  \n",
       "113  ALLERGAN HERBERT DIV ALLERGAN INC  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Now let's build the complete algorithm to find all ANDAs without therapeutic equivalents\n",
    "\n",
    "def find_andas_without_therapeutic_equivalents(df):\n",
    "    \"\"\"\n",
    "    Find all ANDAs that don't have therapeutic equivalents (NDAs)\n",
    "    with the same API, DF;Route, and Strength\n",
    "    \n",
    "    Parameters:\n",
    "    -----------\n",
    "    df : DataFrame\n",
    "        The DataFrame containing the drug data\n",
    "        \n",
    "    Returns:\n",
    "    --------\n",
    "    DataFrame\n",
    "        A DataFrame containing all ANDA drugs without therapeutic equivalents\n",
    "    \"\"\"\n",
    "    # Create a subset of the data for ANDA applications\n",
    "    anda_subset = df[df['Appl_Type'] == 'A'].copy()\n",
    "    \n",
    "    # Filter out rows with missing values in any of the key columns\n",
    "    anda_subset = anda_subset.dropna(subset=['Ingredient', 'DF;Route', 'Strength'])\n",
    "    \n",
    "    # Create a unique identifier for each drug combination \n",
    "    # to avoid checking the same combination multiple times\n",
    "    anda_subset['drug_id'] = anda_subset['Ingredient'] + '|' + anda_subset['DF;Route'] + '|' + anda_subset['Strength']\n",
    "    \n",
    "    # Get unique drug combinations\n",
    "    unique_drug_combinations = anda_subset['drug_id'].unique()\n",
    "    \n",
    "    # Initialize a list to store results\n",
    "    andas_without_equivalents = []\n",
    "    \n",
    "    # Track combinations we've already checked\n",
    "    checked_combinations = set()\n",
    "    \n",
    "    # Check each unique drug combination\n",
    "    for drug_id in unique_drug_combinations:\n",
    "        if drug_id in checked_combinations:\n",
    "            continue\n",
    "            \n",
    "        # Add to checked combinations\n",
    "        checked_combinations.add(drug_id)\n",
    "        \n",
    "        # Split the drug_id to get individual components\n",
    "        api, df_route, strength = drug_id.split('|')\n",
    "        \n",
    "        # Check if a therapeutic equivalent exists\n",
    "        has_equivalent = check_therapeutic_equivalent(df, api, df_route, strength)\n",
    "        \n",
    "        # If no therapeutic equivalent, add all ANDAs with this combination to the results\n",
    "        if not has_equivalent:\n",
    "            matching_andas = anda_subset[anda_subset['drug_id'] == drug_id]\n",
    "            andas_without_equivalents.append(matching_andas)\n",
    "    \n",
    "    # Combine all results\n",
    "    if andas_without_equivalents:\n",
    "        result = pd.concat(andas_without_equivalents)\n",
    "        return result.drop(columns=['drug_id'])\n",
    "    else:\n",
    "        # Return an empty DataFrame with the same columns if no results found\n",
    "        return pd.DataFrame(columns=anda_subset.drop(columns=['drug_id']).columns)\n",
    "\n",
    "\n",
    "test_subset = ob.copy() #Test subset does a copy of the full orangebook\n",
    "andas_without_nda = find_andas_without_therapeutic_equivalents(test_subset)\n",
    "\n",
    "# Print summary statistics\n",
    "print(f\"Total ANDA applications: {len(test_subset[test_subset['Appl_Type'] == 'A'])}\")\n",
    "print(f\"ANDAs without therapeutic equivalents: {len(andas_without_nda)}\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "7ec3c45a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Our example found in results: False\n",
      "Number of OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg ANDAs without therapeutic equivalents: 0\n",
      "\n",
      "First few ANDAs without therapeutic equivalents:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>EPIFOAM</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>86457</td>\n",
       "      <td>1</td>\n",
       "      <td>BX</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN SPECIALTY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>89440</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-17 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>GENUS LIFESCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>PROCTOFOAM HC</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>86195</td>\n",
       "      <td>1</td>\n",
       "      <td>BX</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN SPECIALTY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>DEXAMETHASONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>AEROSEB-DEX</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "      <td>0.01% **Federal Register determination that pr...</td>\n",
       "      <td>A</td>\n",
       "      <td>83296</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ALLERGAN HERBERT DIV ALLERGAN INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>HYDROCORTISONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>AEROSEB-HC</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "      <td>0.005</td>\n",
       "      <td>A</td>\n",
       "      <td>85805</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ALLERGAN HERBERT DIV ALLERGAN INC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          Ingredient  \\\n",
       "104  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "106  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "107  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "112                                    DEXAMETHASONE   \n",
       "113                                   HYDROCORTISONE   \n",
       "\n",
       "                     DF;Route  \\\n",
       "104  AEROSOL, METERED;TOPICAL   \n",
       "106  AEROSOL, METERED;TOPICAL   \n",
       "107  AEROSOL, METERED;TOPICAL   \n",
       "112           AEROSOL;TOPICAL   \n",
       "113           AEROSOL;TOPICAL   \n",
       "\n",
       "                                            Trade_Name            Applicant  \\\n",
       "104                                            EPIFOAM  MYLAN SPECIALITY LP   \n",
       "106  HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...   GENUS LIFESCIENCES   \n",
       "107                                      PROCTOFOAM HC  MYLAN SPECIALITY LP   \n",
       "112                                        AEROSEB-DEX     ALLERGAN HERBERT   \n",
       "113                                         AEROSEB-HC     ALLERGAN HERBERT   \n",
       "\n",
       "                                              Strength Appl_Type Appl_No  \\\n",
       "104                                              1%;1%         A   86457   \n",
       "106                                              1%;1%         A   89440   \n",
       "107                                              1%;1%         A   86195   \n",
       "112  0.01% **Federal Register determination that pr...         A   83296   \n",
       "113                                              0.005         A   85805   \n",
       "\n",
       "    Product_No TE_Code                  Approval_Date RLD  RS   Type  \\\n",
       "104          1      BX  Approved Prior to Jan 1, 1982  No  No     RX   \n",
       "106          1     NaN            1988-05-17 00:00:00  No  No  DISCN   \n",
       "107          1      BX  Approved Prior to Jan 1, 1982  No  No     RX   \n",
       "112          2     NaN  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "113          1     NaN  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "\n",
       "                   Applicant_Full_Name  \n",
       "104                 MYLAN SPECIALTY LP  \n",
       "106             GENUS LIFESCIENCES INC  \n",
       "107                 MYLAN SPECIALTY LP  \n",
       "112  ALLERGAN HERBERT DIV ALLERGAN INC  \n",
       "113  ALLERGAN HERBERT DIV ALLERGAN INC  "
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Check if our OXYCODONE HYDROCHLORIDE is in the results\n",
    "oxycodone_example = andas_without_nda[\n",
    "    (andas_without_nda['Ingredient'] == 'OXYCODONE HYDROCHLORIDE') & \n",
    "    (andas_without_nda['DF;Route'] == 'TABLET;ORAL') & \n",
    "    (andas_without_nda['Strength'] == '10MG') &\n",
    "    (andas_without_nda[\"Type\"] == \"N\")\n",
    "]\n",
    "\n",
    "print(f\"\\nOur example found in results: {len(oxycodone_example) > 0}\")\n",
    "print(f\"Number of OXYCODONE HYDROCHLORIDE TABLET;ORAL 10mg ANDAs without therapeutic equivalents: {len(oxycodone_example)}\")\n",
    "\n",
    "# Show the first few results\n",
    "print(\"\\nFirst few ANDAs without therapeutic equivalents:\")\n",
    "andas_without_nda.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "c481d6c9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>89440</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-17 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>GENUS LIFESCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>A</td>\n",
       "      <td>71621</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PARKE DAVIS DIV WARNER LAMBERT CO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>A</td>\n",
       "      <td>71739</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PARKE DAVIS DIV WARNER LAMBERT CO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>CAPSULE, COATED PELLETS;ORAL</td>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>PLIVA</td>\n",
       "      <td>EQ 100MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>63187</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1992-06-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PLIVA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>BRECKENRIDGE PHARM</td>\n",
       "      <td>EQ 40MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>203088</td>\n",
       "      <td>4</td>\n",
       "      <td>AB</td>\n",
       "      <td>2018-05-18 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>BRECKENRIDGE PHARMACEUTICAL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36402</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>PHARMADERM</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62460</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-11-09 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PHARMADERM DIV ALTANA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36403</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>QUANTUM PHARMICS</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62509</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1984-04-03 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>QUANTUM PHARMICS LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36405</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TEVA</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62502</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-12-23 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>TEVA PHARMACEUTICALS USA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36417</th>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>TROCHE/LOZENGE;ORAL</td>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>PADDOCK LLC</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76763</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2005-10-28 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PADDOCK LABORATORIES LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36418</th>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>TROCHE/LOZENGE;ORAL</td>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>WEST-WARD PHARMS INT</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76387</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2004-07-29 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>7276 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Ingredient  \\\n",
       "106    HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "120                                     CHOLESTYRAMINE   \n",
       "121                                     CHOLESTYRAMINE   \n",
       "126                                DOXYCYCLINE HYCLATE   \n",
       "171                           DULOXETINE HYDROCHLORIDE   \n",
       "...                                                ...   \n",
       "36402                                         NYSTATIN   \n",
       "36403                                         NYSTATIN   \n",
       "36405                                         NYSTATIN   \n",
       "36417                                     CLOTRIMAZOLE   \n",
       "36418                                     CLOTRIMAZOLE   \n",
       "\n",
       "                                DF;Route  \\\n",
       "106             AEROSOL, METERED;TOPICAL   \n",
       "120                   BAR, CHEWABLE;ORAL   \n",
       "121                   BAR, CHEWABLE;ORAL   \n",
       "126         CAPSULE, COATED PELLETS;ORAL   \n",
       "171    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "...                                  ...   \n",
       "36402                     TABLET;VAGINAL   \n",
       "36403                     TABLET;VAGINAL   \n",
       "36405                     TABLET;VAGINAL   \n",
       "36417                TROCHE/LOZENGE;ORAL   \n",
       "36418                TROCHE/LOZENGE;ORAL   \n",
       "\n",
       "                                              Trade_Name  \\\n",
       "106    HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROC...   \n",
       "120                                             CHOLYBAR   \n",
       "121                                             CHOLYBAR   \n",
       "126                                  DOXYCYCLINE HYCLATE   \n",
       "171                             DULOXETINE HYDROCHLORIDE   \n",
       "...                                                  ...   \n",
       "36402                                           NYSTATIN   \n",
       "36403                                           NYSTATIN   \n",
       "36405                                           NYSTATIN   \n",
       "36417                                       CLOTRIMAZOLE   \n",
       "36418                                       CLOTRIMAZOLE   \n",
       "\n",
       "                  Applicant          Strength Appl_Type Appl_No Product_No  \\\n",
       "106      GENUS LIFESCIENCES             1%;1%         A   89440          1   \n",
       "120             PARKE DAVIS  EQ 4GM RESIN/BAR         A   71621          1   \n",
       "121             PARKE DAVIS  EQ 4GM RESIN/BAR         A   71739          1   \n",
       "126                   PLIVA     EQ 100MG BASE         A   63187          1   \n",
       "171      BRECKENRIDGE PHARM      EQ 40MG BASE         A  203088          4   \n",
       "...                     ...               ...       ...     ...        ...   \n",
       "36402            PHARMADERM     100,000 UNITS         A   62460          1   \n",
       "36403      QUANTUM PHARMICS     100,000 UNITS         A   62509          1   \n",
       "36405                  TEVA     100,000 UNITS         A   62502          1   \n",
       "36417           PADDOCK LLC              10MG         A   76763          1   \n",
       "36418  WEST-WARD PHARMS INT              10MG         A   76387          1   \n",
       "\n",
       "      TE_Code        Approval_Date RLD   RS   Type  \\\n",
       "106       NaN  1988-05-17 00:00:00  No   No  DISCN   \n",
       "120       NaN  1988-05-26 00:00:00  No   No  DISCN   \n",
       "121       NaN  1988-05-26 00:00:00  No   No  DISCN   \n",
       "126       NaN  1992-06-30 00:00:00  No   No  DISCN   \n",
       "171        AB  2018-05-18 00:00:00  No   No     RX   \n",
       "...       ...                  ...  ..  ...    ...   \n",
       "36402     NaN  1983-11-09 00:00:00  No   No  DISCN   \n",
       "36403     NaN  1984-04-03 00:00:00  No   No  DISCN   \n",
       "36405     NaN  1983-12-23 00:00:00  No   No  DISCN   \n",
       "36417      AB  2005-10-28 00:00:00  No   No     RX   \n",
       "36418      AB  2004-07-29 00:00:00  No  Yes     RX   \n",
       "\n",
       "                               Applicant_Full_Name  \n",
       "106                         GENUS LIFESCIENCES INC  \n",
       "120              PARKE DAVIS DIV WARNER LAMBERT CO  \n",
       "121              PARKE DAVIS DIV WARNER LAMBERT CO  \n",
       "126                                      PLIVA INC  \n",
       "171                BRECKENRIDGE PHARMACEUTICAL INC  \n",
       "...                                            ...  \n",
       "36402                    PHARMADERM DIV ALTANA INC  \n",
       "36403                         QUANTUM PHARMICS LTD  \n",
       "36405                 TEVA PHARMACEUTICALS USA INC  \n",
       "36417                     PADDOCK LABORATORIES LLC  \n",
       "36418  WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD  \n",
       "\n",
       "[7276 rows x 14 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "andas_without_nda[andas_without_nda[\"Approval_Date\"] != \"Approved Prior to Jan 1, 1982\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "c2cd25f6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>36395</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>KOROSTATIN</td>\n",
       "      <td>HOLLAND RANTOS</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>61718</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>HOLLAND RANTOS CO INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36398</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>MYCOSTATIN</td>\n",
       "      <td>DELCOR ASSET CORP</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>60577</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>DELCOR ASSET CORP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36399</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NILSTAT</td>\n",
       "      <td>LEDERLE</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>61325</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36400</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>FOUGERA</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62459</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-11-09 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>E FOUGERA DIV ALTANA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36401</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>ODYSSEY PHARMS</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62615</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1985-10-17 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ODYSSEY PHARMACEUTICALS INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36402</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>PHARMADERM</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62460</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-11-09 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PHARMADERM DIV ALTANA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36403</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>QUANTUM PHARMICS</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62509</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1984-04-03 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>QUANTUM PHARMICS LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36404</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>SANDOZ</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>61965</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>SANDOZ INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36405</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TEVA</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62502</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-12-23 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>TEVA PHARMACEUTICALS USA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36406</th>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>TABLET;VAGINAL</td>\n",
       "      <td>NYSTATIN</td>\n",
       "      <td>WATSON LABS</td>\n",
       "      <td>100,000 UNITS</td>\n",
       "      <td>A</td>\n",
       "      <td>62176</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>WATSON LABORATORIES INC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Ingredient        DF;Route  Trade_Name          Applicant  \\\n",
       "36395   NYSTATIN  TABLET;VAGINAL  KOROSTATIN     HOLLAND RANTOS   \n",
       "36398   NYSTATIN  TABLET;VAGINAL  MYCOSTATIN  DELCOR ASSET CORP   \n",
       "36399   NYSTATIN  TABLET;VAGINAL     NILSTAT            LEDERLE   \n",
       "36400   NYSTATIN  TABLET;VAGINAL    NYSTATIN            FOUGERA   \n",
       "36401   NYSTATIN  TABLET;VAGINAL    NYSTATIN     ODYSSEY PHARMS   \n",
       "36402   NYSTATIN  TABLET;VAGINAL    NYSTATIN         PHARMADERM   \n",
       "36403   NYSTATIN  TABLET;VAGINAL    NYSTATIN   QUANTUM PHARMICS   \n",
       "36404   NYSTATIN  TABLET;VAGINAL    NYSTATIN             SANDOZ   \n",
       "36405   NYSTATIN  TABLET;VAGINAL    NYSTATIN               TEVA   \n",
       "36406   NYSTATIN  TABLET;VAGINAL    NYSTATIN        WATSON LABS   \n",
       "\n",
       "            Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "36395  100,000 UNITS         A   61718          1     NaN   \n",
       "36398  100,000 UNITS         A   60577          1     NaN   \n",
       "36399  100,000 UNITS         A   61325          1     NaN   \n",
       "36400  100,000 UNITS         A   62459          1     NaN   \n",
       "36401  100,000 UNITS         A   62615          1     NaN   \n",
       "36402  100,000 UNITS         A   62460          1     NaN   \n",
       "36403  100,000 UNITS         A   62509          1     NaN   \n",
       "36404  100,000 UNITS         A   61965          1     NaN   \n",
       "36405  100,000 UNITS         A   62502          1     NaN   \n",
       "36406  100,000 UNITS         A   62176          1     NaN   \n",
       "\n",
       "                       Approval_Date RLD  RS   Type  \\\n",
       "36395  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "36398  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "36399  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "36400            1983-11-09 00:00:00  No  No  DISCN   \n",
       "36401            1985-10-17 00:00:00  No  No  DISCN   \n",
       "36402            1983-11-09 00:00:00  No  No  DISCN   \n",
       "36403            1984-04-03 00:00:00  No  No  DISCN   \n",
       "36404  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "36405            1983-12-23 00:00:00  No  No  DISCN   \n",
       "36406  Approved Prior to Jan 1, 1982  No  No  DISCN   \n",
       "\n",
       "                                 Applicant_Full_Name  \n",
       "36395                          HOLLAND RANTOS CO INC  \n",
       "36398                              DELCOR ASSET CORP  \n",
       "36399  LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO  \n",
       "36400                       E FOUGERA DIV ALTANA INC  \n",
       "36401                    ODYSSEY PHARMACEUTICALS INC  \n",
       "36402                      PHARMADERM DIV ALTANA INC  \n",
       "36403                           QUANTUM PHARMICS LTD  \n",
       "36404                                     SANDOZ INC  \n",
       "36405                   TEVA PHARMACEUTICALS USA INC  \n",
       "36406                        WATSON LABORATORIES INC  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Corrected query for NYSTATIN TABLET;VAGINAL with Strength 100,000 UNIT\n",
    "ob.query('Ingredient == \"NYSTATIN\" and `DF;Route` == \"TABLET;VAGINAL\" and Strength == \"100,000 UNITS\"')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "b0a2cdd0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total ANDAs without NDAs: 9016\n",
      "Unique therapeutic equivalent combinations without NDAs: 1733\n",
      "\n",
      "NYSTATIN TABLET;VAGINAL 100,000 UNITS found in unique results: True\n",
      "\n",
      "First 10 unique therapeutic equivalent combinations without NDAs:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>EPIFOAM</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>DEXAMETHASONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>0.01% **Federal Register determination that pr...</td>\n",
       "      <td>AEROSEB-DEX</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>HYDROCORTISONE</td>\n",
       "      <td>AEROSOL;TOPICAL</td>\n",
       "      <td>0.005</td>\n",
       "      <td>AEROSEB-HC</td>\n",
       "      <td>ALLERGAN HERBERT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>CAPSULE, COATED PELLETS;ORAL</td>\n",
       "      <td>EQ 100MG BASE</td>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>PLIVA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>EQ 40MG BASE</td>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>BRECKENRIDGE PHARM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>10MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>20MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>40MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>CAPSULE, DELAYED RELEASE;ORAL</td>\n",
       "      <td>EQ 20MG BASE</td>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>DR REDDYS LABS LTD</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          Ingredient  \\\n",
       "104  HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "112                                    DEXAMETHASONE   \n",
       "113                                   HYDROCORTISONE   \n",
       "120                                   CHOLESTYRAMINE   \n",
       "126                              DOXYCYCLINE HYCLATE   \n",
       "171                         DULOXETINE HYDROCHLORIDE   \n",
       "276                                       OMEPRAZOLE   \n",
       "277                                       OMEPRAZOLE   \n",
       "278                                       OMEPRAZOLE   \n",
       "363                             OMEPRAZOLE MAGNESIUM   \n",
       "\n",
       "                              DF;Route  \\\n",
       "104           AEROSOL, METERED;TOPICAL   \n",
       "112                    AEROSOL;TOPICAL   \n",
       "113                    AEROSOL;TOPICAL   \n",
       "120                 BAR, CHEWABLE;ORAL   \n",
       "126       CAPSULE, COATED PELLETS;ORAL   \n",
       "171  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "276  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "277  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "278  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "363      CAPSULE, DELAYED RELEASE;ORAL   \n",
       "\n",
       "                                              Strength  \\\n",
       "104                                              1%;1%   \n",
       "112  0.01% **Federal Register determination that pr...   \n",
       "113                                              0.005   \n",
       "120                                   EQ 4GM RESIN/BAR   \n",
       "126                                      EQ 100MG BASE   \n",
       "171                                       EQ 40MG BASE   \n",
       "276                                               10MG   \n",
       "277                                               20MG   \n",
       "278                                               40MG   \n",
       "363                                       EQ 20MG BASE   \n",
       "\n",
       "                   Trade_Name            Applicant  \n",
       "104                   EPIFOAM  MYLAN SPECIALITY LP  \n",
       "112               AEROSEB-DEX     ALLERGAN HERBERT  \n",
       "113                AEROSEB-HC     ALLERGAN HERBERT  \n",
       "120                  CHOLYBAR          PARKE DAVIS  \n",
       "126       DOXYCYCLINE HYCLATE                PLIVA  \n",
       "171  DULOXETINE HYDROCHLORIDE   BRECKENRIDGE PHARM  \n",
       "276                OMEPRAZOLE  ACTAVIS LABS FL INC  \n",
       "277                OMEPRAZOLE  ACTAVIS LABS FL INC  \n",
       "278                OMEPRAZOLE  ACTAVIS LABS FL INC  \n",
       "363      OMEPRAZOLE MAGNESIUM   DR REDDYS LABS LTD  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Filter andas_without_nda to show only unique therapeutic equivalent combinations\n",
    "# This will give us one representative result for each unique combination of Ingredient + DF;Route + Strength\n",
    "\n",
    "unique_therapeutic_equivalents = andas_without_nda.drop_duplicates(\n",
    "    subset=['Ingredient', 'DF;Route', 'Strength'], \n",
    "    keep='first'  # Keep the first occurrence of each unique combination\n",
    ")\n",
    "\n",
    "print(f\"Total ANDAs without NDAs: {len(andas_without_nda)}\")\n",
    "print(f\"Unique therapeutic equivalent combinations without NDAs: {len(unique_therapeutic_equivalents)}\")\n",
    "\n",
    "# Let's verify with the NYSTATIN example\n",
    "nystatin_example = unique_therapeutic_equivalents[\n",
    "    (unique_therapeutic_equivalents['Ingredient'] == 'NYSTATIN') & \n",
    "    (unique_therapeutic_equivalents['DF;Route'] == 'TABLET;VAGINAL') & \n",
    "    (unique_therapeutic_equivalents['Strength'] == '100,000 UNITS')\n",
    "]\n",
    "\n",
    "print(f\"\\nNYSTATIN TABLET;VAGINAL 100,000 UNITS found in unique results: {len(nystatin_example) > 0}\")\n",
    "\n",
    "# Display the first few unique therapeutic equivalent combinations\n",
    "print(\"\\nFirst 10 unique therapeutic equivalent combinations without NDAs:\")\n",
    "unique_therapeutic_equivalents[['Ingredient', 'DF;Route', 'Strength', 'Trade_Name', 'Applicant']].head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "8ea661b7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unique therapeutic equivalents (all): 1733\n",
      "Unique therapeutic equivalents (approved after Jan 1, 1982): 1266\n",
      "\n",
      "Filtered dataset contains 1266 unique therapeutic equivalent combinations approved after Jan 1, 1982\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Approval_Date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "      <td>1988-05-26 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>CAPSULE, COATED PELLETS;ORAL</td>\n",
       "      <td>EQ 100MG BASE</td>\n",
       "      <td>DOXYCYCLINE HYCLATE</td>\n",
       "      <td>PLIVA</td>\n",
       "      <td>1992-06-30 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>EQ 40MG BASE</td>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>BRECKENRIDGE PHARM</td>\n",
       "      <td>2018-05-18 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>10MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>20MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>40MG</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>CAPSULE, DELAYED RELEASE;ORAL</td>\n",
       "      <td>EQ 20MG BASE</td>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>DR REDDYS LABS LTD</td>\n",
       "      <td>2009-06-05 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>THEOPHYLLINE</td>\n",
       "      <td>CAPSULE, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>65MG</td>\n",
       "      <td>AEROLATE III</td>\n",
       "      <td>FLEMING PHARMS</td>\n",
       "      <td>1986-11-24 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>THEOPHYLLINE</td>\n",
       "      <td>CAPSULE, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>130MG</td>\n",
       "      <td>AEROLATE JR</td>\n",
       "      <td>FLEMING PHARMS</td>\n",
       "      <td>1986-11-24 00:00:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>THEOPHYLLINE</td>\n",
       "      <td>CAPSULE, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>260MG</td>\n",
       "      <td>AEROLATE SR</td>\n",
       "      <td>FLEMING PHARMS</td>\n",
       "      <td>1986-11-24 00:00:00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Ingredient                           DF;Route  \\\n",
       "120            CHOLESTYRAMINE                 BAR, CHEWABLE;ORAL   \n",
       "126       DOXYCYCLINE HYCLATE       CAPSULE, COATED PELLETS;ORAL   \n",
       "171  DULOXETINE HYDROCHLORIDE  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "276                OMEPRAZOLE  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "277                OMEPRAZOLE  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "278                OMEPRAZOLE  CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "363      OMEPRAZOLE MAGNESIUM      CAPSULE, DELAYED RELEASE;ORAL   \n",
       "406              THEOPHYLLINE     CAPSULE, EXTENDED RELEASE;ORAL   \n",
       "407              THEOPHYLLINE     CAPSULE, EXTENDED RELEASE;ORAL   \n",
       "408              THEOPHYLLINE     CAPSULE, EXTENDED RELEASE;ORAL   \n",
       "\n",
       "             Strength                Trade_Name            Applicant  \\\n",
       "120  EQ 4GM RESIN/BAR                  CHOLYBAR          PARKE DAVIS   \n",
       "126     EQ 100MG BASE       DOXYCYCLINE HYCLATE                PLIVA   \n",
       "171      EQ 40MG BASE  DULOXETINE HYDROCHLORIDE   BRECKENRIDGE PHARM   \n",
       "276              10MG                OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "277              20MG                OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "278              40MG                OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "363      EQ 20MG BASE      OMEPRAZOLE MAGNESIUM   DR REDDYS LABS LTD   \n",
       "406              65MG              AEROLATE III       FLEMING PHARMS   \n",
       "407             130MG               AEROLATE JR       FLEMING PHARMS   \n",
       "408             260MG               AEROLATE SR       FLEMING PHARMS   \n",
       "\n",
       "           Approval_Date  \n",
       "120  1988-05-26 00:00:00  \n",
       "126  1992-06-30 00:00:00  \n",
       "171  2018-05-18 00:00:00  \n",
       "276  2008-05-30 00:00:00  \n",
       "277  2008-05-30 00:00:00  \n",
       "278  2008-05-30 00:00:00  \n",
       "363  2009-06-05 00:00:00  \n",
       "406  1986-11-24 00:00:00  \n",
       "407  1986-11-24 00:00:00  \n",
       "408  1986-11-24 00:00:00  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Filter unique therapeutic equivalents to exclude those approved prior to Jan 1, 1982\n",
    "unique_therapeutic_equivalents_post_1982 = unique_therapeutic_equivalents[\n",
    "    unique_therapeutic_equivalents[\"Approval_Date\"] != \"Approved Prior to Jan 1, 1982\"\n",
    "]\n",
    "\n",
    "print(f\"Unique therapeutic equivalents (all): {len(unique_therapeutic_equivalents)}\")\n",
    "print(f\"Unique therapeutic equivalents (approved after Jan 1, 1982): {len(unique_therapeutic_equivalents_post_1982)}\")\n",
    "\n",
    "# Display the filtered results\n",
    "print(f\"\\nFiltered dataset contains {len(unique_therapeutic_equivalents_post_1982)} unique therapeutic equivalent combinations approved after Jan 1, 1982\")\n",
    "\n",
    "# Show the first few results\n",
    "unique_therapeutic_equivalents_post_1982[['Ingredient', 'DF;Route', 'Strength', 'Trade_Name', 'Applicant', 'Approval_Date']].head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "69bb31d8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>A</td>\n",
       "      <td>71621</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PARKE DAVIS DIV WARNER LAMBERT CO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>BAR, CHEWABLE;ORAL</td>\n",
       "      <td>CHOLYBAR</td>\n",
       "      <td>PARKE DAVIS</td>\n",
       "      <td>EQ 4GM RESIN/BAR</td>\n",
       "      <td>A</td>\n",
       "      <td>71739</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1988-05-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>PARKE DAVIS DIV WARNER LAMBERT CO</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Ingredient            DF;Route Trade_Name    Applicant  \\\n",
       "120  CHOLESTYRAMINE  BAR, CHEWABLE;ORAL   CHOLYBAR  PARKE DAVIS   \n",
       "121  CHOLESTYRAMINE  BAR, CHEWABLE;ORAL   CHOLYBAR  PARKE DAVIS   \n",
       "\n",
       "             Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "120  EQ 4GM RESIN/BAR         A   71621          1     NaN   \n",
       "121  EQ 4GM RESIN/BAR         A   71739          1     NaN   \n",
       "\n",
       "           Approval_Date RLD  RS   Type                Applicant_Full_Name  \n",
       "120  1988-05-26 00:00:00  No  No  DISCN  PARKE DAVIS DIV WARNER LAMBERT CO  \n",
       "121  1988-05-26 00:00:00  No  No  DISCN  PARKE DAVIS DIV WARNER LAMBERT CO  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ob.query('Ingredient == \"CHOLESTYRAMINE\" and `DF;Route` == \"BAR, CHEWABLE;ORAL\" and Strength == \"EQ 4GM RESIN/BAR\"')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e4f6a5ed",
   "metadata": {},
   "source": [
    "filtered dataset to show only the unique therapeutic equivalent combinations that were approved after January 1, 1982. Here's what the filtering accomplished:\n",
    "\n",
    "Original unique combinations: 1,733\n",
    "After filtering out pre-1982 approvals: 1,266\n",
    "This gives you 1,266 unique therapeutic equivalent drug combinations that:\n",
    "\n",
    "Exist as ANDAs (generic applications)\n",
    "Do NOT have corresponding NDA (brand-name) therapeutic equivalents\n",
    "Were approved after January 1, 1982"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "48ace22c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Display the complete unique_therapeutic_equivalents dataset with all fields\n",
    "print(f\"Complete unique therapeutic equivalents dataset with all {len(unique_therapeutic_equivalents.columns)} fields:\")\n",
    "print(f\"Total records: {len(unique_therapeutic_equivalents)}\")\n",
    "print(f\"\\nColumn names: {list(unique_therapeutic_equivalents.columns)}\")\n",
    "\n",
    "# Display the full dataset\n",
    "unique_therapeutic_equivalents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bb4cca30",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE</td>\n",
       "      <td>AEROSOL, METERED;TOPICAL</td>\n",
       "      <td>EPIFOAM</td>\n",
       "      <td>MYLAN SPECIALITY LP</td>\n",
       "      <td>1%;1%</td>\n",
       "      <td>A</td>\n",
       "      <td>86457</td>\n",
       "      <td>1</td>\n",
       "      <td>BX</td>\n",
       "      <td>Approved Prior to Jan 1, 1982</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN SPECIALTY LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>BRECKENRIDGE PHARM</td>\n",
       "      <td>EQ 40MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>203088</td>\n",
       "      <td>4</td>\n",
       "      <td>AB</td>\n",
       "      <td>2018-05-18 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>BRECKENRIDGE PHARMACEUTICAL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>20MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>40MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>3</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36263</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 2MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>90819</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2015-02-19 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36264</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 8MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>90819</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2015-02-19 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36279</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 2MG BASE;EQ 0.5MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>91422</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2013-02-22 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36317</th>\n",
       "      <td>ERGOTAMINE TARTRATE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>ERGOMAR</td>\n",
       "      <td>TERSERA THERAPS LLC</td>\n",
       "      <td>2MG</td>\n",
       "      <td>A</td>\n",
       "      <td>87693</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-02-24 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>TERSERA THERAPEUTICS LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36417</th>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>TROCHE/LOZENGE;ORAL</td>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>PADDOCK LLC</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76763</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2005-10-28 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PADDOCK LABORATORIES LLC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>680 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Ingredient  \\\n",
       "104      HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE   \n",
       "171                             DULOXETINE HYDROCHLORIDE   \n",
       "276                                           OMEPRAZOLE   \n",
       "277                                           OMEPRAZOLE   \n",
       "278                                           OMEPRAZOLE   \n",
       "...                                                  ...   \n",
       "36263                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36264                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36279  BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...   \n",
       "36317                                ERGOTAMINE TARTRATE   \n",
       "36417                                       CLOTRIMAZOLE   \n",
       "\n",
       "                                DF;Route  \\\n",
       "104             AEROSOL, METERED;TOPICAL   \n",
       "171    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "276    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "277    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "278    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "...                                  ...   \n",
       "36263                  TABLET;SUBLINGUAL   \n",
       "36264                  TABLET;SUBLINGUAL   \n",
       "36279                  TABLET;SUBLINGUAL   \n",
       "36317                  TABLET;SUBLINGUAL   \n",
       "36417                TROCHE/LOZENGE;ORAL   \n",
       "\n",
       "                                              Trade_Name            Applicant  \\\n",
       "104                                              EPIFOAM  MYLAN SPECIALITY LP   \n",
       "171                             DULOXETINE HYDROCHLORIDE   BRECKENRIDGE PHARM   \n",
       "276                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "277                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "278                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "...                                                  ...                  ...   \n",
       "36263                        BUPRENORPHINE HYDROCHLORIDE    ACTAVIS ELIZABETH   \n",
       "36264                        BUPRENORPHINE HYDROCHLORIDE    ACTAVIS ELIZABETH   \n",
       "36279  BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...    ACTAVIS ELIZABETH   \n",
       "36317                                            ERGOMAR  TERSERA THERAPS LLC   \n",
       "36417                                       CLOTRIMAZOLE          PADDOCK LLC   \n",
       "\n",
       "                        Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "104                        1%;1%         A   86457          1      BX   \n",
       "171                 EQ 40MG BASE         A  203088          4      AB   \n",
       "276                         10MG         A   75347          1      AB   \n",
       "277                         20MG         A   75347          2      AB   \n",
       "278                         40MG         A   75347          3      AB   \n",
       "...                          ...       ...     ...        ...     ...   \n",
       "36263                EQ 2MG BASE         A   90819          1      AB   \n",
       "36264                EQ 8MG BASE         A   90819          2      AB   \n",
       "36279  EQ 2MG BASE;EQ 0.5MG BASE         A   91422          1      AB   \n",
       "36317                        2MG         A   87693          1     NaN   \n",
       "36417                       10MG         A   76763          1      AB   \n",
       "\n",
       "                       Approval_Date RLD   RS Type  \\\n",
       "104    Approved Prior to Jan 1, 1982  No   No   RX   \n",
       "171              2018-05-18 00:00:00  No   No   RX   \n",
       "276              2008-05-30 00:00:00  No   No   RX   \n",
       "277              2008-05-30 00:00:00  No   No   RX   \n",
       "278              2008-05-30 00:00:00  No   No   RX   \n",
       "...                              ...  ..  ...  ...   \n",
       "36263            2015-02-19 00:00:00  No   No   RX   \n",
       "36264            2015-02-19 00:00:00  No   No   RX   \n",
       "36279            2013-02-22 00:00:00  No   No   RX   \n",
       "36317            1983-02-24 00:00:00  No  Yes   RX   \n",
       "36417            2005-10-28 00:00:00  No   No   RX   \n",
       "\n",
       "                   Applicant_Full_Name  \n",
       "104                 MYLAN SPECIALTY LP  \n",
       "171    BRECKENRIDGE PHARMACEUTICAL INC  \n",
       "276        ACTAVIS LABORATORIES FL INC  \n",
       "277        ACTAVIS LABORATORIES FL INC  \n",
       "278        ACTAVIS LABORATORIES FL INC  \n",
       "...                                ...  \n",
       "36263            ACTAVIS ELIZABETH LLC  \n",
       "36264            ACTAVIS ELIZABETH LLC  \n",
       "36279            ACTAVIS ELIZABETH LLC  \n",
       "36317         TERSERA THERAPEUTICS LLC  \n",
       "36417         PADDOCK LABORATORIES LLC  \n",
       "\n",
       "[680 rows x 14 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_therapeutic_equivalents[unique_therapeutic_equivalents[\"Type\"] != \"DISCN\"]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "01f6778b",
   "metadata": {},
   "source": [
    "Of the drugs without NDAs only 680 are discontinued as of 2018."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "019192ad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "      <td>BRECKENRIDGE PHARM</td>\n",
       "      <td>EQ 40MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>203088</td>\n",
       "      <td>4</td>\n",
       "      <td>AB</td>\n",
       "      <td>2018-05-18 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>BRECKENRIDGE PHARMACEUTICAL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>20MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>ACTAVIS LABS FL INC</td>\n",
       "      <td>40MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75347</td>\n",
       "      <td>3</td>\n",
       "      <td>AB</td>\n",
       "      <td>2008-05-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS LABORATORIES FL INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>CAPSULE, DELAYED RELEASE;ORAL</td>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>DR REDDYS LABS LTD</td>\n",
       "      <td>EQ 20MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>78878</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-06-05 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>OTC</td>\n",
       "      <td>DR REDDYS LABORATORIES LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36263</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 2MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>90819</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2015-02-19 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36264</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 8MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>90819</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2015-02-19 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36279</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 2MG BASE;EQ 0.5MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>91422</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2013-02-22 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36317</th>\n",
       "      <td>ERGOTAMINE TARTRATE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>ERGOMAR</td>\n",
       "      <td>TERSERA THERAPS LLC</td>\n",
       "      <td>2MG</td>\n",
       "      <td>A</td>\n",
       "      <td>87693</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-02-24 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>TERSERA THERAPEUTICS LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36417</th>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>TROCHE/LOZENGE;ORAL</td>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>PADDOCK LLC</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76763</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2005-10-28 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PADDOCK LABORATORIES LLC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>642 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Ingredient  \\\n",
       "171                             DULOXETINE HYDROCHLORIDE   \n",
       "276                                           OMEPRAZOLE   \n",
       "277                                           OMEPRAZOLE   \n",
       "278                                           OMEPRAZOLE   \n",
       "363                                 OMEPRAZOLE MAGNESIUM   \n",
       "...                                                  ...   \n",
       "36263                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36264                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36279  BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...   \n",
       "36317                                ERGOTAMINE TARTRATE   \n",
       "36417                                       CLOTRIMAZOLE   \n",
       "\n",
       "                                DF;Route  \\\n",
       "171    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "276    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "277    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "278    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "363        CAPSULE, DELAYED RELEASE;ORAL   \n",
       "...                                  ...   \n",
       "36263                  TABLET;SUBLINGUAL   \n",
       "36264                  TABLET;SUBLINGUAL   \n",
       "36279                  TABLET;SUBLINGUAL   \n",
       "36317                  TABLET;SUBLINGUAL   \n",
       "36417                TROCHE/LOZENGE;ORAL   \n",
       "\n",
       "                                              Trade_Name            Applicant  \\\n",
       "171                             DULOXETINE HYDROCHLORIDE   BRECKENRIDGE PHARM   \n",
       "276                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "277                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "278                                           OMEPRAZOLE  ACTAVIS LABS FL INC   \n",
       "363                                 OMEPRAZOLE MAGNESIUM   DR REDDYS LABS LTD   \n",
       "...                                                  ...                  ...   \n",
       "36263                        BUPRENORPHINE HYDROCHLORIDE    ACTAVIS ELIZABETH   \n",
       "36264                        BUPRENORPHINE HYDROCHLORIDE    ACTAVIS ELIZABETH   \n",
       "36279  BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...    ACTAVIS ELIZABETH   \n",
       "36317                                            ERGOMAR  TERSERA THERAPS LLC   \n",
       "36417                                       CLOTRIMAZOLE          PADDOCK LLC   \n",
       "\n",
       "                        Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "171                 EQ 40MG BASE         A  203088          4      AB   \n",
       "276                         10MG         A   75347          1      AB   \n",
       "277                         20MG         A   75347          2      AB   \n",
       "278                         40MG         A   75347          3      AB   \n",
       "363                 EQ 20MG BASE         A   78878          1     NaN   \n",
       "...                          ...       ...     ...        ...     ...   \n",
       "36263                EQ 2MG BASE         A   90819          1      AB   \n",
       "36264                EQ 8MG BASE         A   90819          2      AB   \n",
       "36279  EQ 2MG BASE;EQ 0.5MG BASE         A   91422          1      AB   \n",
       "36317                        2MG         A   87693          1     NaN   \n",
       "36417                       10MG         A   76763          1      AB   \n",
       "\n",
       "             Approval_Date RLD   RS Type              Applicant_Full_Name  \n",
       "171    2018-05-18 00:00:00  No   No   RX  BRECKENRIDGE PHARMACEUTICAL INC  \n",
       "276    2008-05-30 00:00:00  No   No   RX      ACTAVIS LABORATORIES FL INC  \n",
       "277    2008-05-30 00:00:00  No   No   RX      ACTAVIS LABORATORIES FL INC  \n",
       "278    2008-05-30 00:00:00  No   No   RX      ACTAVIS LABORATORIES FL INC  \n",
       "363    2009-06-05 00:00:00  No  Yes  OTC       DR REDDYS LABORATORIES LTD  \n",
       "...                    ...  ..  ...  ...                              ...  \n",
       "36263  2015-02-19 00:00:00  No   No   RX            ACTAVIS ELIZABETH LLC  \n",
       "36264  2015-02-19 00:00:00  No   No   RX            ACTAVIS ELIZABETH LLC  \n",
       "36279  2013-02-22 00:00:00  No   No   RX            ACTAVIS ELIZABETH LLC  \n",
       "36317  1983-02-24 00:00:00  No  Yes   RX         TERSERA THERAPEUTICS LLC  \n",
       "36417  2005-10-28 00:00:00  No   No   RX         PADDOCK LABORATORIES LLC  \n",
       "\n",
       "[642 rows x 14 columns]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_therapeutic_equivalents_post_1982[unique_therapeutic_equivalents_post_1982[\"Type\"] != \"DISCN\"]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1b197578",
   "metadata": {},
   "source": [
    "Even of the drugs approved since 1982, 642 unique PE drugs do not have NDAs listed in the orange book and are not marked as discontinued."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "b6a34faf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36458"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(ob)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "e93a52d1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE</td>\n",
       "      <td>CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;...</td>\n",
       "      <td>LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN</td>\n",
       "      <td>RISING PHARMS</td>\n",
       "      <td>500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG</td>\n",
       "      <td>A</td>\n",
       "      <td>206006</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2016-10-07 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>RISING PHARMACEUTICALS INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>SANDOZ</td>\n",
       "      <td>20MG</td>\n",
       "      <td>A</td>\n",
       "      <td>75757</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2003-01-28 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>SANDOZ INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>CAPSULE, DELAYED REL PELLETS;ORAL</td>\n",
       "      <td>OMEPRAZOLE</td>\n",
       "      <td>SANDOZ</td>\n",
       "      <td>40MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76515</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2009-01-21 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>SANDOZ INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>CAPSULE, DELAYED RELEASE;ORAL</td>\n",
       "      <td>OMEPRAZOLE MAGNESIUM</td>\n",
       "      <td>DR REDDYS LABS LTD</td>\n",
       "      <td>EQ 20MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>78878</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-06-05 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>OTC</td>\n",
       "      <td>DR REDDYS LABORATORIES LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>DILTIAZEM HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>DILTIAZEM HYDROCHLORIDE</td>\n",
       "      <td>MYLAN</td>\n",
       "      <td>120MG</td>\n",
       "      <td>A</td>\n",
       "      <td>74910</td>\n",
       "      <td>3</td>\n",
       "      <td>BC</td>\n",
       "      <td>1997-05-02 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>MYLAN PHARMACEUTICALS INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36249</th>\n",
       "      <td>ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE</td>\n",
       "      <td>TABLET;ORAL-28</td>\n",
       "      <td>ZOVIA 1/50E-28</td>\n",
       "      <td>WATSON LABS</td>\n",
       "      <td>0.05MG;1MG</td>\n",
       "      <td>A</td>\n",
       "      <td>72723</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>1991-12-30 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>WATSON LABORATORIES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36278</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE</td>\n",
       "      <td>WEST-WARD PHARMS INT</td>\n",
       "      <td>EQ 8MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>78633</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2009-10-08 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36280</th>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...</td>\n",
       "      <td>ACTAVIS ELIZABETH</td>\n",
       "      <td>EQ 8MG BASE;EQ 2MG BASE</td>\n",
       "      <td>A</td>\n",
       "      <td>91422</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2013-02-22 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>ACTAVIS ELIZABETH LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36317</th>\n",
       "      <td>ERGOTAMINE TARTRATE</td>\n",
       "      <td>TABLET;SUBLINGUAL</td>\n",
       "      <td>ERGOMAR</td>\n",
       "      <td>TERSERA THERAPS LLC</td>\n",
       "      <td>2MG</td>\n",
       "      <td>A</td>\n",
       "      <td>87693</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-02-24 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>TERSERA THERAPEUTICS LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36418</th>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>TROCHE/LOZENGE;ORAL</td>\n",
       "      <td>CLOTRIMAZOLE</td>\n",
       "      <td>WEST-WARD PHARMS INT</td>\n",
       "      <td>10MG</td>\n",
       "      <td>A</td>\n",
       "      <td>76387</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2004-07-29 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1013 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Ingredient  \\\n",
       "122            AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE   \n",
       "311                                           OMEPRAZOLE   \n",
       "312                                           OMEPRAZOLE   \n",
       "363                                 OMEPRAZOLE MAGNESIUM   \n",
       "620                              DILTIAZEM HYDROCHLORIDE   \n",
       "...                                                  ...   \n",
       "36249            ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE   \n",
       "36278                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36280  BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHL...   \n",
       "36317                                ERGOTAMINE TARTRATE   \n",
       "36418                                       CLOTRIMAZOLE   \n",
       "\n",
       "                                                DF;Route  \\\n",
       "122    CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;...   \n",
       "311                    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "312                    CAPSULE, DELAYED REL PELLETS;ORAL   \n",
       "363                        CAPSULE, DELAYED RELEASE;ORAL   \n",
       "620                       CAPSULE, EXTENDED RELEASE;ORAL   \n",
       "...                                                  ...   \n",
       "36249                                     TABLET;ORAL-28   \n",
       "36278                                  TABLET;SUBLINGUAL   \n",
       "36280                                  TABLET;SUBLINGUAL   \n",
       "36317                                  TABLET;SUBLINGUAL   \n",
       "36418                                TROCHE/LOZENGE;ORAL   \n",
       "\n",
       "                                              Trade_Name  \\\n",
       "122         LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN   \n",
       "311                                           OMEPRAZOLE   \n",
       "312                                           OMEPRAZOLE   \n",
       "363                                 OMEPRAZOLE MAGNESIUM   \n",
       "620                              DILTIAZEM HYDROCHLORIDE   \n",
       "...                                                  ...   \n",
       "36249                                     ZOVIA 1/50E-28   \n",
       "36278                        BUPRENORPHINE HYDROCHLORIDE   \n",
       "36280  BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRO...   \n",
       "36317                                            ERGOMAR   \n",
       "36418                                       CLOTRIMAZOLE   \n",
       "\n",
       "                  Applicant                                  Strength  \\\n",
       "122           RISING PHARMS  500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG   \n",
       "311                  SANDOZ                                      20MG   \n",
       "312                  SANDOZ                                      40MG   \n",
       "363      DR REDDYS LABS LTD                              EQ 20MG BASE   \n",
       "620                   MYLAN                                     120MG   \n",
       "...                     ...                                       ...   \n",
       "36249           WATSON LABS                                0.05MG;1MG   \n",
       "36278  WEST-WARD PHARMS INT                               EQ 8MG BASE   \n",
       "36280     ACTAVIS ELIZABETH                   EQ 8MG BASE;EQ 2MG BASE   \n",
       "36317   TERSERA THERAPS LLC                                       2MG   \n",
       "36418  WEST-WARD PHARMS INT                                      10MG   \n",
       "\n",
       "      Appl_Type Appl_No Product_No TE_Code        Approval_Date RLD   RS Type  \\\n",
       "122           A  206006          1      AB  2016-10-07 00:00:00  No  Yes   RX   \n",
       "311           A   75757          2      AB  2003-01-28 00:00:00  No  Yes   RX   \n",
       "312           A   76515          1      AB  2009-01-21 00:00:00  No  Yes   RX   \n",
       "363           A   78878          1     NaN  2009-06-05 00:00:00  No  Yes  OTC   \n",
       "620           A   74910          3      BC  1997-05-02 00:00:00  No  Yes   RX   \n",
       "...         ...     ...        ...     ...                  ...  ..  ...  ...   \n",
       "36249         A   72723          1      AB  1991-12-30 00:00:00  No  Yes   RX   \n",
       "36278         A   78633          2      AB  2009-10-08 00:00:00  No  Yes   RX   \n",
       "36280         A   91422          2      AB  2013-02-22 00:00:00  No  Yes   RX   \n",
       "36317         A   87693          1     NaN  1983-02-24 00:00:00  No  Yes   RX   \n",
       "36418         A   76387          1      AB  2004-07-29 00:00:00  No  Yes   RX   \n",
       "\n",
       "                               Applicant_Full_Name  \n",
       "122                     RISING PHARMACEUTICALS INC  \n",
       "311                                     SANDOZ INC  \n",
       "312                                     SANDOZ INC  \n",
       "363                     DR REDDYS LABORATORIES LTD  \n",
       "620                      MYLAN PHARMACEUTICALS INC  \n",
       "...                                            ...  \n",
       "36249                      WATSON LABORATORIES INC  \n",
       "36278  WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD  \n",
       "36280                        ACTAVIS ELIZABETH LLC  \n",
       "36317                     TERSERA THERAPEUTICS LLC  \n",
       "36418  WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD  \n",
       "\n",
       "[1013 rows x 14 columns]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Filter for ANDAs that are either RLD or RS\n",
    "ob.query('Appl_Type == \"A\" and (RLD == \"Yes\" or RS == \"Yes\")')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4bb1fd19",
   "metadata": {},
   "source": [
    "There are 1013 ANDAs servis are the RDS or RLS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "f893ca51",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3487</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>CAPSULE;ORAL</td>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>5MG</td>\n",
       "      <td>N</td>\n",
       "      <td>200534</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2010-10-20 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>GENUS LIFE SCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16604</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>SOLUTION;ORAL</td>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>5MG/5ML</td>\n",
       "      <td>N</td>\n",
       "      <td>200535</td>\n",
       "      <td>2</td>\n",
       "      <td>AA</td>\n",
       "      <td>2013-08-22 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>GENUS LIFE SCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16605</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>SOLUTION;ORAL</td>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>GENUS LIFESCIENCES</td>\n",
       "      <td>100MG/5ML</td>\n",
       "      <td>N</td>\n",
       "      <td>200535</td>\n",
       "      <td>1</td>\n",
       "      <td>AA</td>\n",
       "      <td>2010-10-20 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>GENUS LIFE SCIENCES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16614</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>SOLUTION;ORAL</td>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>VISTAPHARM</td>\n",
       "      <td>5MG/5ML</td>\n",
       "      <td>N</td>\n",
       "      <td>201194</td>\n",
       "      <td>1</td>\n",
       "      <td>AA</td>\n",
       "      <td>2012-01-12 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>VISTAPHARM INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19765</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>10MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19766</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>15MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19767</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>20MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19768</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>30MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19769</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>40MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19770</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>60MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19771</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>80MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33476</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>ROXICODONE</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "      <td>5MG</td>\n",
       "      <td>N</td>\n",
       "      <td>21011</td>\n",
       "      <td>3</td>\n",
       "      <td>AB</td>\n",
       "      <td>2009-05-15 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33477</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>ROXICODONE</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "      <td>15MG</td>\n",
       "      <td>N</td>\n",
       "      <td>21011</td>\n",
       "      <td>1</td>\n",
       "      <td>AB</td>\n",
       "      <td>2000-08-31 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33478</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>ROXICODONE</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "      <td>30MG</td>\n",
       "      <td>N</td>\n",
       "      <td>21011</td>\n",
       "      <td>2</td>\n",
       "      <td>AB</td>\n",
       "      <td>2000-08-31 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>SPECGX LLC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Ingredient                       DF;Route  \\\n",
       "3487   OXYCODONE HYDROCHLORIDE                   CAPSULE;ORAL   \n",
       "16604  OXYCODONE HYDROCHLORIDE                  SOLUTION;ORAL   \n",
       "16605  OXYCODONE HYDROCHLORIDE                  SOLUTION;ORAL   \n",
       "16614  OXYCODONE HYDROCHLORIDE                  SOLUTION;ORAL   \n",
       "19765  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19766  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19767  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19768  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19769  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19770  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "19771  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   \n",
       "33476  OXYCODONE HYDROCHLORIDE                    TABLET;ORAL   \n",
       "33477  OXYCODONE HYDROCHLORIDE                    TABLET;ORAL   \n",
       "33478  OXYCODONE HYDROCHLORIDE                    TABLET;ORAL   \n",
       "\n",
       "                    Trade_Name           Applicant   Strength Appl_Type  \\\n",
       "3487   OXYCODONE HYDROCHLORIDE  GENUS LIFESCIENCES        5MG         N   \n",
       "16604  OXYCODONE HYDROCHLORIDE  GENUS LIFESCIENCES    5MG/5ML         N   \n",
       "16605  OXYCODONE HYDROCHLORIDE  GENUS LIFESCIENCES  100MG/5ML         N   \n",
       "16614  OXYCODONE HYDROCHLORIDE          VISTAPHARM    5MG/5ML         N   \n",
       "19765                OXYCONTIN    PURDUE PHARMA LP       10MG         N   \n",
       "19766                OXYCONTIN    PURDUE PHARMA LP       15MG         N   \n",
       "19767                OXYCONTIN    PURDUE PHARMA LP       20MG         N   \n",
       "19768                OXYCONTIN    PURDUE PHARMA LP       30MG         N   \n",
       "19769                OXYCONTIN    PURDUE PHARMA LP       40MG         N   \n",
       "19770                OXYCONTIN    PURDUE PHARMA LP       60MG         N   \n",
       "19771                OXYCONTIN    PURDUE PHARMA LP       80MG         N   \n",
       "33476               ROXICODONE          SPECGX LLC        5MG         N   \n",
       "33477               ROXICODONE          SPECGX LLC       15MG         N   \n",
       "33478               ROXICODONE          SPECGX LLC       30MG         N   \n",
       "\n",
       "      Appl_No Product_No TE_Code        Approval_Date  RLD   RS Type  \\\n",
       "3487   200534          1      AB  2010-10-20 00:00:00  Yes  Yes   RX   \n",
       "16604  200535          2      AA  2013-08-22 00:00:00  Yes   No   RX   \n",
       "16605  200535          1      AA  2010-10-20 00:00:00  Yes  Yes   RX   \n",
       "16614  201194          1      AA  2012-01-12 00:00:00  Yes  Yes   RX   \n",
       "19765   22272          1     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "19766   22272          2     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "19767   22272          3     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "19768   22272          4     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "19769   22272          5     NaN  2010-04-05 00:00:00  Yes  Yes   RX   \n",
       "19770   22272          6     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "19771   22272          7     NaN  2010-04-05 00:00:00  Yes   No   RX   \n",
       "33476   21011          3      AB  2009-05-15 00:00:00  Yes   No   RX   \n",
       "33477   21011          1      AB  2000-08-31 00:00:00  Yes  Yes   RX   \n",
       "33478   21011          2      AB  2000-08-31 00:00:00  Yes   No   RX   \n",
       "\n",
       "           Applicant_Full_Name  \n",
       "3487   GENUS LIFE SCIENCES INC  \n",
       "16604  GENUS LIFE SCIENCES INC  \n",
       "16605  GENUS LIFE SCIENCES INC  \n",
       "16614           VISTAPHARM INC  \n",
       "19765         PURDUE PHARMA LP  \n",
       "19766         PURDUE PHARMA LP  \n",
       "19767         PURDUE PHARMA LP  \n",
       "19768         PURDUE PHARMA LP  \n",
       "19769         PURDUE PHARMA LP  \n",
       "19770         PURDUE PHARMA LP  \n",
       "19771         PURDUE PHARMA LP  \n",
       "33476               SPECGX LLC  \n",
       "33477               SPECGX LLC  \n",
       "33478               SPECGX LLC  "
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Find RLD or RS for OXYCODONE HYDROCHLORIDE\n",
    "ob.query('Ingredient == \"OXYCODONE HYDROCHLORIDE\" and (RLD == \"Yes\" or RS == \"Yes\")')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "71daa7da",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ingredient</th>\n",
       "      <th>DF;Route</th>\n",
       "      <th>Trade_Name</th>\n",
       "      <th>Applicant</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Appl_Type</th>\n",
       "      <th>Appl_No</th>\n",
       "      <th>Product_No</th>\n",
       "      <th>TE_Code</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>RLD</th>\n",
       "      <th>RS</th>\n",
       "      <th>Type</th>\n",
       "      <th>Applicant_Full_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>19765</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>10MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19766</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>15MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19767</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>20MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19768</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>30MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19769</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>40MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19770</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>60MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19771</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>OXYCONTIN</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "      <td>80MG</td>\n",
       "      <td>N</td>\n",
       "      <td>22272</td>\n",
       "      <td>7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010-04-05 00:00:00</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>RX</td>\n",
       "      <td>PURDUE PHARMA LP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20094</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>ROXICODONE</td>\n",
       "      <td>ROXANE</td>\n",
       "      <td>10MG</td>\n",
       "      <td>N</td>\n",
       "      <td>20932</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1998-10-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ROXANE LABORATORIES INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20095</th>\n",
       "      <td>OXYCODONE HYDROCHLORIDE</td>\n",
       "      <td>TABLET, EXTENDED RELEASE;ORAL</td>\n",
       "      <td>ROXICODONE</td>\n",
       "      <td>ROXANE</td>\n",
       "      <td>30MG</td>\n",
       "      <td>N</td>\n",
       "      <td>20932</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1998-10-26 00:00:00</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>DISCN</td>\n",
       "      <td>ROXANE LABORATORIES INC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Ingredient                       DF;Route  Trade_Name  \\\n",
       "19765  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19766  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19767  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19768  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19769  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19770  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "19771  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL   OXYCONTIN   \n",
       "20094  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL  ROXICODONE   \n",
       "20095  OXYCODONE HYDROCHLORIDE  TABLET, EXTENDED RELEASE;ORAL  ROXICODONE   \n",
       "\n",
       "              Applicant Strength Appl_Type Appl_No Product_No TE_Code  \\\n",
       "19765  PURDUE PHARMA LP     10MG         N   22272          1     NaN   \n",
       "19766  PURDUE PHARMA LP     15MG         N   22272          2     NaN   \n",
       "19767  PURDUE PHARMA LP     20MG         N   22272          3     NaN   \n",
       "19768  PURDUE PHARMA LP     30MG         N   22272          4     NaN   \n",
       "19769  PURDUE PHARMA LP     40MG         N   22272          5     NaN   \n",
       "19770  PURDUE PHARMA LP     60MG         N   22272          6     NaN   \n",
       "19771  PURDUE PHARMA LP     80MG         N   22272          7     NaN   \n",
       "20094            ROXANE     10MG         N   20932          1     NaN   \n",
       "20095            ROXANE     30MG         N   20932          2     NaN   \n",
       "\n",
       "             Approval_Date  RLD   RS   Type      Applicant_Full_Name  \n",
       "19765  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "19766  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "19767  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "19768  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "19769  2010-04-05 00:00:00  Yes  Yes     RX         PURDUE PHARMA LP  \n",
       "19770  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "19771  2010-04-05 00:00:00  Yes   No     RX         PURDUE PHARMA LP  \n",
       "20094  1998-10-26 00:00:00   No   No  DISCN  ROXANE LABORATORIES INC  \n",
       "20095  1998-10-26 00:00:00   No   No  DISCN  ROXANE LABORATORIES INC  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ob.query('Ingredient == \"OXYCODONE HYDROCHLORIDE\" and `DF;Route` == \"TABLET, EXTENDED RELEASE;ORAL\"')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "d9ae948c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of NDA (Application Type 'N') records: 9628\n"
     ]
    }
   ],
   "source": [
    "nda_count = len(ob[ob['Appl_Type'] == 'N'])\n",
    "print(f\"Number of NDA (Application Type 'N') records: {nda_count}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "16f065c0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1400x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Orange Book Analysis Summary:\n",
      "========================================\n",
      "Total Records in Dataset: 36,458\n",
      "Total NDAs: 9,628\n",
      "Total ANDAs: 26,830\n",
      "ANDAs without NDA Equivalents: 9,016\n"
     ]
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "# Data from your analysis\n",
    "categories = [\n",
    "    'Total Records\\nin Dataset',\n",
    "    'Total NDAs',\n",
    "    'Total ANDAs', \n",
    "    'ANDAs without\\nNDA Equivalents',\n",
    "]\n",
    "\n",
    "# Values from your analysis\n",
    "values = [\n",
    "    len(ob),  # Total records\n",
    "    len(ob[ob['Appl_Type'] == 'N']),  # Total NDAs\n",
    "    len(ob[ob['Appl_Type'] == 'A']),  # Total ANDAs\n",
    "    len(andas_without_nda),  # ANDAs without NDA equivalents\n",
    "]\n",
    "\n",
    "# Create the bar graph\n",
    "fig, ax = plt.subplots(figsize=(14, 8))\n",
    "bars = ax.bar(categories, values, color=['#1f77b4', '#ff7f0e', '#2ca02c', '#d62728', '#9467bd', '#8c564b', '#e377c2', '#7f7f7f'])\n",
    "\n",
    "# Customize the plot\n",
    "ax.set_ylabel('Number of Records', fontsize=12)\n",
    "ax.set_title('Orange Book Missing Data Summary', fontsize=14, fontweight='bold', pad=20)\n",
    "\n",
    "# Add value labels on top of bars\n",
    "for bar, value in zip(bars, values):\n",
    "    height = bar.get_height()\n",
    "    ax.text(bar.get_x() + bar.get_width()/2., height + max(values)*0.01,\n",
    "            f'{value:,}', ha='center', va='bottom', fontweight='bold')\n",
    "\n",
    "# Rotate x-axis labels for better readability\n",
    "plt.xticks(rotation=45, ha='right')\n",
    "\n",
    "# Add grid for better readability\n",
    "ax.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "\n",
    "# Set y-axis to start from 0 and add some padding at the top\n",
    "ax.set_ylim(0, max(values) * 1.1)\n",
    "\n",
    "# Format y-axis with comma separators\n",
    "ax.yaxis.set_major_formatter(plt.FuncFormatter(lambda x, p: f'{int(x):,}'))\n",
    "\n",
    "# Adjust layout to prevent label cutoff\n",
    "plt.tight_layout()\n",
    "\n",
    "# Display the plot\n",
    "plt.show()\n",
    "\n",
    "# Print summary statistics\n",
    "print(\"Orange Book Analysis Summary:\")\n",
    "print(\"=\" * 40)\n",
    "for category, value in zip(categories, values):\n",
    "    print(f\"{category.replace(chr(10), ' ')}: {value:,}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "f7770452",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Focused Analysis Summary:\n",
      "========================================\n",
      "Unique Therapeutic Combinations without NDAs: 1,733\n",
      "Post-1982 Unique Combinations: 1,266\n",
      "Post-1982 PE (Not Discontinued): 642\n",
      "ANDAs that are RLD or RS: 1,013\n"
     ]
    }
   ],
   "source": [
    "focused_categories = [\n",
    "    'Unique Therapeutic\\nCombinations without NDAs',\n",
    "    'Post-1982 Unique\\nCombinations',\n",
    "    'Post-1982 PE\\n(Not Discontinued)',\n",
    "    'ANDAs that are\\nRLD or RS'\n",
    "]\n",
    "\n",
    "# Values for these specific categories\n",
    "focused_values = [\n",
    "    len(unique_therapeutic_equivalents),  \n",
    "    len(unique_therapeutic_equivalents_post_1982), \n",
    "    len(unique_therapeutic_equivalents_post_1982[unique_therapeutic_equivalents_post_1982[\"Type\"] != \"DISCN\"]),  # Active post-1982 (642)\n",
    "    1013  \n",
    "]\n",
    "\n",
    "# Create the focused bar graph\n",
    "fig, ax = plt.subplots(figsize=(12, 6))\n",
    "bars = ax.bar(focused_categories, focused_values, color=['#9467bd', '#8c564b', '#e377c2', '#7f7f7f'])\n",
    "\n",
    "# Customize the plot\n",
    "ax.set_ylabel('Number of Records', fontsize=12)\n",
    "ax.set_title('Orange Book Therapeutic Equivalents Analysis', fontsize=14, fontweight='bold', pad=20)\n",
    "\n",
    "# Add value labels on top of bars\n",
    "for bar, value in zip(bars, focused_values):\n",
    "    height = bar.get_height()\n",
    "    ax.text(bar.get_x() + bar.get_width()/2., height + max(focused_values)*0.01,\n",
    "            f'{value:,}', ha='center', va='bottom', fontweight='bold', fontsize=11)\n",
    "\n",
    "# Rotate x-axis labels for better readability\n",
    "plt.xticks(rotation=45, ha='right')\n",
    "\n",
    "# Add grid for better readability\n",
    "ax.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "\n",
    "# Set y-axis to start from 0 and add some padding at the top\n",
    "ax.set_ylim(0, max(focused_values) * 1.1)\n",
    "\n",
    "# Format y-axis with comma separators\n",
    "ax.yaxis.set_major_formatter(plt.FuncFormatter(lambda x, p: f'{int(x):,}'))\n",
    "\n",
    "# Adjust layout to prevent label cutoff\n",
    "plt.tight_layout()\n",
    "\n",
    "# Display the plot\n",
    "plt.show()\n",
    "\n",
    "# Print summary for these 4 categories\n",
    "print(\"Focused Analysis Summary:\")\n",
    "print(\"=\" * 40)\n",
    "for category, value in zip(focused_categories, focused_values):\n",
    "    print(f\"{category.replace(chr(10), ' ')}: {value:,}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b8dcddaa",
   "metadata": {},
   "source": [
    "# Company Validation Analysis\n",
    "\n",
    "Now let's test our new company validation system using real PDF extraction from ANDA approval letters. This will show how the system validates NDA-ANDA matches by cross-referencing company information."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "37cb4e5f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import our company validation system\n",
    "import sys\n",
    "sys.path.append(r'C:\\Users\\Grove\\OneDrive\\Documents\\PYTHON\\Datasets\\EDA Feldman')\n",
    "\n",
    "from extract_from_pdf import FDAApprovalLetterExtractor\n",
    "from postprocess import get_nda_companies_from_main_table, calculate_text_similarity\n",
    "from preprocess import preprocess_data\n",
    "\n",
    "# Initialize the PDF extractor\n",
    "extractor = FDAApprovalLetterExtractor()\n",
    "\n",
    "print(\"Company Validation System loaded successfully!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eee458c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Test extraction from actual PDFs for the ANDAs you mentioned\n",
    "test_andas = [\n",
    "    {'anda': 'ANDA 077780', 'url': 'https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/077780Orig1s000ltr.pdf', 'expected': 'GLAXOSMITHKLINE'},\n",
    "    {'anda': 'ANDA 076470', 'url': 'https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/076470Orig1s000ltr.pdf', 'expected': 'Aventis Pharmaceutical products'},\n",
    "    {'anda': 'ANDA 088888', 'url': None, 'expected': 'No valid PDF'}  # This one should fail\n",
    "]\n",
    "\n",
    "print(\"Testing actual PDF extraction for the corrected ANDAs...\")\n",
    "print(\"=\" * 60)\n",
    "\n",
    "for test_case in test_andas:\n",
    "    anda = test_case['anda']\n",
    "    url = test_case['url']\n",
    "    expected = test_case['expected']\n",
    "    \n",
    "    print(f\"\\nðŸ” Testing {anda}\")\n",
    "    print(f\"Expected: {expected}\")\n",
    "    \n",
    "    if url is None:\n",
    "        print(\"âŒ No URL provided - this should fail as expected\")\n",
    "        continue\n",
    "    \n",
    "    try:\n",
    "        # Extract data from the actual PDF\n",
    "        result = extractor.extract_from_pdf(url)\n",
    "        \n",
    "        if result:\n",
    "            extracted_company = result.get('reference_company', 'Not found')\n",
    "            print(f\"âœ… PDF extraction successful\")\n",
    "            print(f\"Extracted company: {extracted_company}\")\n",
    "            \n",
    "            # Check if extraction matches expectation\n",
    "            if extracted_company and expected.upper() in extracted_company.upper():\n",
    "                print(f\"âœ… MATCH: Extracted company contains expected text\")\n",
    "            elif extracted_company:\n",
    "                print(f\"âš ï¸  PARTIAL: Extracted '{extracted_company}' vs expected '{expected}'\")\n",
    "            else:\n",
    "                print(f\"âŒ NO COMPANY: No company extracted from PDF\")\n",
    "        else:\n",
    "            print(f\"âŒ PDF extraction failed\")\n",
    "            \n",
    "    except Exception as e:\n",
    "        print(f\"âŒ Error extracting from PDF: {str(e)}\")\n",
    "    \n",
    "    print(\"-\" * 40)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "73131734",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now let's test our company validation system with the actual extracted companies\n",
    "print(\"\\n\" + \"=\" * 60)\n",
    "print(\"TESTING COMPANY VALIDATION SYSTEM\")\n",
    "print(\"=\" * 60)\n",
    "\n",
    "# Load the main table to get NDA companies\n",
    "try:\n",
    "    main_table_path = r'C:\\Users\\Grove\\OneDrive\\Documents\\PYTHON\\Datasets\\EDA Feldman\\Copy of Main Table - Dosage Strength.xlsx'\n",
    "    nda_companies = get_nda_companies_from_main_table(main_table_path)\n",
    "    print(f\"âœ… Loaded {len(nda_companies)} NDA companies from main table\")\n",
    "except Exception as e:\n",
    "    print(f\"âŒ Error loading main table: {e}\")\n",
    "    nda_companies = {}\n",
    "\n",
    "# Test cases with actual extracted companies vs NDA companies\n",
    "validation_tests = [\n",
    "    {\n",
    "        'anda': 'ANDA 077780',\n",
    "        'extracted': 'GLAXOSMITHKLINE',  # This is what you said should be extracted\n",
    "        'nda': 'N021868',  # Example NDA for testing\n",
    "        'description': 'Should validate as GlaxoSmithKline match'\n",
    "    },\n",
    "    {\n",
    "        'anda': 'ANDA 076470', \n",
    "        'extracted': 'Aventis Pharmaceutical products',  # This is what you said should be extracted\n",
    "        'nda': 'N021868',  # Example NDA for testing\n",
    "        'description': 'Should show Aventis vs NDA company comparison'\n",
    "    }\n",
    "]\n",
    "\n",
    "for test in validation_tests:\n",
    "    print(f\"\\nðŸ§ª Testing: {test['anda']}\")\n",
    "    print(f\"Description: {test['description']}\")\n",
    "    print(f\"Extracted company: {test['extracted']}\")\n",
    "    \n",
    "    # Get the NDA company for comparison\n",
    "    if test['nda'] in nda_companies:\n",
    "        nda_company = nda_companies[test['nda']]\n",
    "        print(f\"NDA company: {nda_company}\")\n",
    "        \n",
    "        # Calculate similarity\n",
    "        similarity = calculate_text_similarity(test['extracted'], nda_company)\n",
    "        print(f\"Similarity score: {similarity:.2%}\")\n",
    "        \n",
    "        if similarity >= 0.9:\n",
    "            print(\"âœ… VALIDATION PASSED (>90% similarity)\")\n",
    "        elif similarity >= 0.7:\n",
    "            print(\"âš ï¸  PARTIAL MATCH (70-90% similarity)\")\n",
    "        else:\n",
    "            print(\"âŒ VALIDATION FAILED (<70% similarity)\")\n",
    "    else:\n",
    "        print(f\"âŒ NDA {test['nda']} not found in main table\")\n",
    "    \n",
    "    print(\"-\" * 40)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv (3.13.3)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
